Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations already declare readOnlyHint=true, so the safety profile is covered. The description adds that results span all labels and are paginated, plus the underlying v2 endpoint, but adds nothing about result volume, ordering, or rate limits beyond what the schema's page/pagesize hints imply.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Is the description appropriately sized, front-loaded, and free of redundancy?

One front-loaded sentence carries the payload, with the DailyMed v2 endpoint appended as a compact cross-reference. Slightly redundant given pagination is already in the schema, but nothing is bloated.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

For a two-parameter read-only list endpoint with no output schema, the description names the returned entities and one returned field, which is enough for an agent to call it correctly. It stops short of enumerating the full return shape or ordering.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema description coverage is 100% and both parameters (page, pagesize) are fully documented in the schema, so the baseline is 3. The word 'paginated' restates the schema rather than adding syntax or constraint detail beyond it.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Does the description clearly state what the tool does and how it differs from similar tools?

States a specific verb (List) and resource (FDA application numbers, qualified as NDA/ANDA/BLA) plus the fields returned (marketing category code). The resource is naturally distinct from siblings like dailymed_list_ndcs or dailymed_list_drug_classes, but the description never explicitly contrasts itself with those list endpoints.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Does the description explain when to use this tool, when not to, or what alternatives exist?

No when-to-use, when-not-to-use, or alternative selection guidance is provided. The only implicit cue is the resource name itself; nothing tells an agent whether to prefer this over dailymed_search_labels or the other list_* siblings.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.